Somerset, NJ, United States of America

Harshkumar Patel

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harshkumar Patel. Retrieved from https://idiyas.com/inventor/harshkumar-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harshkumar Patel: Innovator in Chemical Compounds

Introduction

Harshkumar Patel is a notable inventor based in Somerset, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds that serve as LPA antagonists. His work is characterized by a focus on improving methods for synthesizing complex chemical structures.

Latest Patents

Harshkumar Patel holds a patent for a process titled "Process for preparing carbamoyloxymethyl triazole cyclohexyl acid compounds." This patent describes improved methods and intermediates for preparing these compounds, which are valuable in various applications, particularly in pharmaceutical research.

Career Highlights

Currently, Harshkumar Patel is employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves extensive research and development, contributing to innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Harshkumar has collaborated with esteemed colleagues, including Richard J. Fox and Carlos A. Guerrero. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Harshkumar Patel's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing pharmaceutical research. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…